#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Depression Pemphigoid Gestational trophoblastic tumour Acute myeloid leukaemia Waldenstrom's macroglobulinaemia Conjunctivitis allergic Pelizaeus-Merzbacher disease Philadelphia positive chronic myeloid leukaemia Acquired ATTR amyloidosis Gastric cancer Small cell lung cancer extensive stage Epstein-Barr virus associated lymphoproliferative disorder Spinal cord injury cervical Dementia Alzheimer's type Hyperchylomicronaemia More trials…

    Learn about Rare Diseases

    Advanced systemic mastocytosis – Life with Disease Breast angiosarcoma Osteosarcoma recurrent – Trials in Disease Mantle cell lymphoma refractory – Life with Disease Mucopolysaccharidosis III – Diagnostics Osteosarcoma – Basic Information Haemophilia B without inhibitors – Life with Disease Nodal marginal zone B-cell lymphoma – Diagnostics Congenital generalised lipodystrophy Anaplastic thyroid cancer – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Interferon Gamma Ginisortamab Abc-23B-116 ADCE-D01 Ixekizumab Peginterferon Alfa-2A Acp-017 Ticagrelor Jab-21822 Somatostatin Rugonersen Rifapentine Pembrolizumab Vincristine Sulfate Amlitelimab Fingolimod Hydrochloride Ranibizumab Odm-111 Tiaprofenic Acid Bbp-398 More therapies…

    Learn about Your Condition

    Malignant oligodendroglioma Arthritis infective Acquired haemophilia Pterygium Gastric cancer stage IV Dysmenorrhoea Henoch-Schonlein purpura Mechanical ventilation Diabetic autonomic neuropathy Papillary thyroid cancer Frontotemporal dementia Acute on chronic liver failure Fragile X syndrome Dry mouth Procedural hypotension More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Safety and Effects of [68Ga]Ga-DPI-4452 and [177Lu]Lu-DPI-4452 in Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ductal adenocarcinoma of pancreas
    • Clear cell renal cell carcinoma
    • Colorectal cancer
    Investigated Drugs:
    • 177Lu-Dpi-4452
    • 68Ga-Dpi-4452
    • Acetazolamide
    Belgium France

  • Study on Fluasterone for Managing High Blood Sugar in Adults with Cushing’s Syndrome

    Recruiting

    2 1
    Investigated Diseases:
    • Cushing’s syndrome
    Investigated Drugs:
    • Fluasterone
    Greece

  • Study on the Effectiveness and Safety of NS-229 for Patients with Eosinophilic Granulomatosis with Polyangiitis

    Recruiting

    2 1
    Investigated Diseases:
    • Eosinophilic granulomatosis with polyangiitis
    Investigated Drugs:
    • Methyl-(1-{[6-{[(1S)-1-Cyclopropylethyl]Amino}-2-(Pyrazolo[5,1-B][1,3]Thiazol-7-Yl)-Pyrimidin-4-Yl]Carbonyl}Piperidin-4-Yl)Carbamate-Mono(4-Methylbenzenesulfonate) Monohydrate
    France Germany Italy Spain

  • Study on N-Acetyl-L-Leucine for Patients with Niemann-Pick Disease Type C

    Recruiting

    3 1
    Investigated Drugs:
    • L-Acetylleucine
    Czechia Germany The Netherlands Slovakia

  • Study on Glofitamab and Drug Combination for Children and Young Adults with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • B-cell lymphoma
    Investigated Drugs:
    • Glofitamab
    • Ifosfamide
    • Obinutuzumab
    Czechia Denmark France Germany Hungary Italy +2

  • Study on the Long-Term Safety of Finerenone with ACE Inhibitors or ARBs for Children and Young Adults with Chronic Kidney Disease and Proteinuria

    Recruiting

    3 1 1
    Investigated Diseases:
    • Proteinuria
    • Chronic kidney disease
    Investigated Drugs:
    • Finerenone
    Austria Belgium Bulgaria Czechia Denmark Finland +11
Previous Page
1 … 456 457 458 459 460 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!